Millie
your market intelligence analyst
Search Results
356 results
Your search is now limited to «Roche» expert search.
FiercePharmaManufacturing 12/08/2019 11:19
ORLANDO—AbbVie and Roche have been fielding their fair share of questions about how well their fixed-duration regimen of Venclexta and Rituxan could keep chronic lymphocytic leukemia from returning after therapy ends.
More from FiercePharmaManufacturing:
Hoffmann-La Roche (EU) 12/07/2019 09:00
Mosunetuzumab and CD20-TCB differ in their structures, and both are being developed by Roche as part of our ongoing strategy to explore multiple bispecific formats, to identify those that maximise potential clinical benefits for patients.
More from Hoffmann-La Roche (EU):
Reuters.com 12/05/2019 14:10
U.S. Food and Drug Administration:
More from Reuters.com:
PR Newswire 12/04/2019 14:40
The Company and its consolidated subsidiaries, including the Offeror and Genentech, are referred to hereinafter as the "Roche Group.
More from PR Newswire:
Xconomy 12/04/2019 10:53
A Roche immunotherapy has won an additional FDA approval as a first-line treatment for non-small lung cancer, bolstering the product’s competitive stance versus one from Merck.
More from Xconomy:
NASDAQ 12/04/2019 09:22
Roche Holdings AG RHHBY announced that the FDA has approved a label expansion of its immuno-oncology drug Tecentriq (atezolizumab.
More from NASDAQ:
ENDPOINTS 12/04/2019 07:19
Roche has nailed down the FDA approval it needs to catch up with Merck in frontline non-squamous non-small cell lung cancer, positioning Tecentriq for a broader swath of patients.
More from ENDPOINTS:
Roche gets FDA nod for Tecentriq plus chemotherapy to treat NSCLC.
More from Pharmaceutical Business Review:
ETHealthWorld (India) 12/04/2019 02:10
Roche wins FDA approval for immunotherapy cocktail against lung cancer, Health News, ET HealthWorld.
More from ETHealthWorld (India):
Channel NewsAsia (Singapore) 12/04/2019 01:20
Roche wins FDA approval for immunotherapy cocktail against lung cancer.
More from Channel NewsAsia (Singapore):
Seeking Alpha 12/03/2019 08:53
Roche (OTCQX:RHHBY) has come into the field armed with FDA priority review status for its drug risdiplam.
More from Seeking Alpha:
(MENAFN - GetNews) MRSA Antibiotics Comprehensive Study byType (Vancomycin, Teicoplanin, Linezolid, Cubicin, Others), Route of Administration (Oral, Parenteral), Distribution Chann...
More from Middle East North Africa Financial Network (MENAFN):
PMLiVE 12/02/2019 06:12
The results from Roche’s pivotal phase 3 study of satralizumab, SakuraSky, were published in the New England Journal of Medicine (NEJM.
More from PMLiVE:
Pharmafile 12/02/2019 05:27
Roche's satralizumab shows promise at Phase 3 in neuromyelitis optica spectrum disorder.
More from Pharmafile:
World Pharma News 11/27/2019 06:00
Roche leads the clinical development of risdiplam as part of a collaboration with the SMA Foundation and PTC Therapeutics, and would commercialize the medicine in the United States if approved.
More from World Pharma News:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications